Concepts (322)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Iran | 117 | 2024 | 708 | 7.290 |
Why?
|
Prediabetic State | 8 | 2023 | 499 | 2.760 |
Why?
|
Cardiovascular Diseases | 49 | 2024 | 15161 | 2.470 |
Why?
|
Diabetes Mellitus, Type 2 | 37 | 2023 | 11732 | 2.120 |
Why?
|
Glucose Intolerance | 4 | 2023 | 577 | 2.090 |
Why?
|
Diabetes Mellitus | 17 | 2023 | 5755 | 1.620 |
Why?
|
Glucose | 21 | 2023 | 4396 | 1.540 |
Why?
|
Lipids | 32 | 2023 | 3305 | 1.470 |
Why?
|
Congenital Hypothyroidism | 4 | 2021 | 39 | 1.260 |
Why?
|
Blood Glucose | 31 | 2023 | 6259 | 1.240 |
Why?
|
Hypertension | 19 | 2023 | 8480 | 1.020 |
Why?
|
Life Style | 6 | 2020 | 3835 | 0.930 |
Why?
|
Risk Factors | 77 | 2024 | 72280 | 0.830 |
Why?
|
Coronary Disease | 8 | 2018 | 6078 | 0.720 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2020 | 3256 | 0.660 |
Why?
|
Health Education | 3 | 2020 | 1055 | 0.630 |
Why?
|
Incidence | 37 | 2022 | 20945 | 0.620 |
Why?
|
Waist Circumference | 13 | 2023 | 917 | 0.610 |
Why?
|
Female | 119 | 2024 | 380197 | 0.570 |
Why?
|
Adult | 93 | 2023 | 214035 | 0.570 |
Why?
|
Decision Trees | 2 | 2014 | 506 | 0.540 |
Why?
|
Middle Aged | 79 | 2023 | 213367 | 0.530 |
Why?
|
Humans | 152 | 2024 | 744220 | 0.520 |
Why?
|
Polycystic Ovary Syndrome | 4 | 2020 | 370 | 0.510 |
Why?
|
Male | 98 | 2024 | 350027 | 0.510 |
Why?
|
Risk Assessment | 19 | 2023 | 23337 | 0.500 |
Why?
|
American Heart Association | 2 | 2018 | 1056 | 0.480 |
Why?
|
Data Mining | 2 | 2015 | 537 | 0.460 |
Why?
|
Body Mass Index | 23 | 2023 | 12718 | 0.440 |
Why?
|
Selection Bias | 1 | 2014 | 371 | 0.430 |
Why?
|
Diabetes, Gestational | 4 | 2023 | 1184 | 0.430 |
Why?
|
Metabolic Diseases | 1 | 2019 | 658 | 0.430 |
Why?
|
Cholesterol, HDL | 6 | 2024 | 1814 | 0.430 |
Why?
|
Smoking | 14 | 2023 | 8986 | 0.430 |
Why?
|
Insulin Resistance | 2 | 2023 | 3863 | 0.420 |
Why?
|
Epidemiologic Studies | 1 | 2015 | 676 | 0.410 |
Why?
|
Middle East | 3 | 2022 | 219 | 0.410 |
Why?
|
Neonatal Screening | 4 | 2021 | 591 | 0.410 |
Why?
|
Follow-Up Studies | 30 | 2023 | 39045 | 0.400 |
Why?
|
Population Surveillance | 4 | 2021 | 2616 | 0.400 |
Why?
|
Triglycerides | 8 | 2024 | 2453 | 0.400 |
Why?
|
Cohort Studies | 24 | 2024 | 40559 | 0.390 |
Why?
|
Blood Pressure | 13 | 2023 | 8551 | 0.390 |
Why?
|
Death Certificates | 1 | 2012 | 169 | 0.390 |
Why?
|
Accidents | 1 | 2012 | 164 | 0.380 |
Why?
|
Exercise | 5 | 2021 | 5615 | 0.380 |
Why?
|
Sex Factors | 13 | 2023 | 10396 | 0.380 |
Why?
|
Health Personnel | 2 | 2022 | 3216 | 0.380 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2021 | 2208 | 0.360 |
Why?
|
Hashimoto Disease | 2 | 2023 | 97 | 0.360 |
Why?
|
Obesity | 16 | 2023 | 12742 | 0.360 |
Why?
|
Aged | 43 | 2023 | 163253 | 0.350 |
Why?
|
Proportional Hazards Models | 16 | 2021 | 12355 | 0.340 |
Why?
|
Dyslipidemias | 4 | 2024 | 849 | 0.340 |
Why?
|
Interleukins | 1 | 2013 | 791 | 0.330 |
Why?
|
Health Status | 4 | 2021 | 4034 | 0.330 |
Why?
|
Premenstrual Syndrome | 2 | 2020 | 109 | 0.320 |
Why?
|
Mass Screening | 3 | 2020 | 5252 | 0.320 |
Why?
|
Prospective Studies | 29 | 2023 | 53280 | 0.310 |
Why?
|
Obesity, Abdominal | 2 | 2023 | 361 | 0.310 |
Why?
|
Angina Pectoris | 1 | 2012 | 977 | 0.310 |
Why?
|
Prehypertension | 2 | 2019 | 61 | 0.290 |
Why?
|
Minority Groups | 1 | 2014 | 1223 | 0.290 |
Why?
|
Adiposity | 7 | 2023 | 1807 | 0.290 |
Why?
|
Longitudinal Studies | 10 | 2023 | 13990 | 0.290 |
Why?
|
Urban Population | 4 | 2021 | 2021 | 0.290 |
Why?
|
Models, Theoretical | 2 | 2015 | 3591 | 0.280 |
Why?
|
Cholesterol | 6 | 2023 | 2911 | 0.270 |
Why?
|
Anthropometry | 3 | 2020 | 1350 | 0.270 |
Why?
|
Glucose Tolerance Test | 3 | 2023 | 1150 | 0.270 |
Why?
|
Area Under Curve | 3 | 2020 | 1655 | 0.250 |
Why?
|
Young Adult | 29 | 2023 | 56436 | 0.250 |
Why?
|
Forecasting | 4 | 2020 | 2949 | 0.250 |
Why?
|
Thyroxine | 4 | 2021 | 666 | 0.240 |
Why?
|
Hypothyroidism | 2 | 2020 | 659 | 0.240 |
Why?
|
Prevalence | 13 | 2021 | 15226 | 0.230 |
Why?
|
Cardiology | 1 | 2015 | 1668 | 0.230 |
Why?
|
Weight Gain | 4 | 2023 | 2292 | 0.230 |
Why?
|
Income | 2 | 2024 | 1913 | 0.220 |
Why?
|
Cause of Death | 2 | 2023 | 3584 | 0.220 |
Why?
|
Hepatitis C | 1 | 2013 | 1591 | 0.220 |
Why?
|
Estrogens | 2 | 2021 | 1565 | 0.220 |
Why?
|
Thyroid Gland | 2 | 2020 | 1172 | 0.220 |
Why?
|
Knowledge | 1 | 2024 | 181 | 0.210 |
Why?
|
Fabaceae | 1 | 2022 | 103 | 0.200 |
Why?
|
Logistic Models | 10 | 2021 | 13409 | 0.200 |
Why?
|
Gastric Bypass | 2 | 2022 | 812 | 0.200 |
Why?
|
Practice Guidelines as Topic | 2 | 2018 | 7281 | 0.200 |
Why?
|
Echium | 1 | 2020 | 3 | 0.190 |
Why?
|
Iodide Peroxidase | 1 | 2023 | 293 | 0.190 |
Why?
|
Contraceptives, Oral | 2 | 2020 | 563 | 0.190 |
Why?
|
Body Weights and Measures | 2 | 2019 | 211 | 0.190 |
Why?
|
Pregnancy in Diabetics | 1 | 2022 | 179 | 0.190 |
Why?
|
Diet | 7 | 2022 | 7937 | 0.190 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 25043 | 0.190 |
Why?
|
Thyroid Function Tests | 1 | 2021 | 284 | 0.180 |
Why?
|
Sulfonylurea Compounds | 1 | 2021 | 204 | 0.180 |
Why?
|
Methimazole | 1 | 2019 | 41 | 0.180 |
Why?
|
Thyrotropin | 2 | 2021 | 850 | 0.180 |
Why?
|
Rural Population | 2 | 2021 | 2210 | 0.180 |
Why?
|
Africa, Northern | 1 | 2019 | 82 | 0.170 |
Why?
|
Levonorgestrel | 1 | 2020 | 77 | 0.170 |
Why?
|
Hypoglycemic Agents | 2 | 2022 | 2875 | 0.170 |
Why?
|
Antithyroid Agents | 1 | 2019 | 70 | 0.170 |
Why?
|
Electrocardiography | 2 | 2012 | 6442 | 0.170 |
Why?
|
Obesity, Morbid | 2 | 2022 | 1213 | 0.170 |
Why?
|
History of Medicine | 1 | 2019 | 35 | 0.170 |
Why?
|
Waist-Hip Ratio | 5 | 2023 | 517 | 0.170 |
Why?
|
Bayes Theorem | 4 | 2024 | 2309 | 0.170 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2020 | 113 | 0.170 |
Why?
|
Quality of Life | 4 | 2021 | 12805 | 0.170 |
Why?
|
Acromegaly | 1 | 2021 | 347 | 0.160 |
Why?
|
Phytotherapy | 1 | 2020 | 298 | 0.160 |
Why?
|
Fetal Macrosomia | 3 | 2023 | 124 | 0.160 |
Why?
|
Prognosis | 11 | 2021 | 29050 | 0.160 |
Why?
|
Amides | 1 | 2021 | 459 | 0.160 |
Why?
|
Australia | 1 | 2021 | 1169 | 0.150 |
Why?
|
Graves Disease | 1 | 2019 | 242 | 0.150 |
Why?
|
Sarcopenia | 1 | 2023 | 368 | 0.150 |
Why?
|
Socioeconomic Factors | 3 | 2019 | 7784 | 0.150 |
Why?
|
Nutritive Value | 1 | 2020 | 339 | 0.150 |
Why?
|
Sex Characteristics | 2 | 2019 | 2586 | 0.150 |
Why?
|
Menarche | 1 | 2020 | 516 | 0.150 |
Why?
|
Gastrectomy | 2 | 2022 | 663 | 0.150 |
Why?
|
Plant Extracts | 1 | 2020 | 472 | 0.150 |
Why?
|
Overweight | 3 | 2022 | 2370 | 0.140 |
Why?
|
Multivariate Analysis | 6 | 2017 | 12244 | 0.140 |
Why?
|
Infant, Newborn, Diseases | 1 | 2022 | 582 | 0.140 |
Why?
|
Odds Ratio | 7 | 2019 | 9849 | 0.140 |
Why?
|
Thyroid Hormones | 1 | 2019 | 390 | 0.140 |
Why?
|
Cluster Analysis | 2 | 2021 | 2715 | 0.140 |
Why?
|
Menstruation Disturbances | 1 | 2017 | 148 | 0.140 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2021 | 3923 | 0.140 |
Why?
|
Human Growth Hormone | 1 | 2021 | 683 | 0.140 |
Why?
|
Probability | 1 | 2021 | 2505 | 0.140 |
Why?
|
Lipoproteins, HDL | 2 | 2023 | 638 | 0.140 |
Why?
|
Guidelines as Topic | 2 | 2020 | 1404 | 0.130 |
Why?
|
Uterine Hemorrhage | 1 | 2017 | 255 | 0.130 |
Why?
|
Aging | 1 | 2014 | 8661 | 0.130 |
Why?
|
Iodine | 1 | 2017 | 286 | 0.130 |
Why?
|
Habits | 1 | 2016 | 139 | 0.130 |
Why?
|
Family Health | 1 | 2020 | 1282 | 0.130 |
Why?
|
Cold Temperature | 1 | 2019 | 774 | 0.130 |
Why?
|
Pyrazines | 1 | 2021 | 1231 | 0.130 |
Why?
|
Models, Statistical | 3 | 2021 | 5102 | 0.130 |
Why?
|
Wrist | 2 | 2014 | 225 | 0.120 |
Why?
|
Educational Status | 2 | 2020 | 2539 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2023 | 2503 | 0.120 |
Why?
|
History, 21st Century | 1 | 2020 | 1534 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 15525 | 0.120 |
Why?
|
Infant, Newborn | 7 | 2023 | 25618 | 0.120 |
Why?
|
Cardiovascular System | 2 | 2019 | 832 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1200 | 0.120 |
Why?
|
Nutritional Status | 2 | 2019 | 1609 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2938 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1782 | 0.110 |
Why?
|
Food Preferences | 1 | 2017 | 399 | 0.110 |
Why?
|
ROC Curve | 2 | 2019 | 3527 | 0.110 |
Why?
|
Osteoporosis | 1 | 2023 | 1580 | 0.110 |
Why?
|
Primary Prevention | 1 | 2020 | 1167 | 0.110 |
Why?
|
Arabs | 1 | 2015 | 178 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 1 | 2021 | 1541 | 0.110 |
Why?
|
Hot Temperature | 1 | 2019 | 1355 | 0.110 |
Why?
|
Bariatric Surgery | 1 | 2022 | 952 | 0.110 |
Why?
|
Pituitary Neoplasms | 1 | 2021 | 1346 | 0.110 |
Why?
|
Health Surveys | 4 | 2021 | 4037 | 0.110 |
Why?
|
Glucose Metabolism Disorders | 1 | 2012 | 54 | 0.110 |
Why?
|
Autoimmunity | 1 | 2020 | 1349 | 0.110 |
Why?
|
Disease Progression | 4 | 2022 | 13280 | 0.110 |
Why?
|
Energy Intake | 1 | 2020 | 2148 | 0.110 |
Why?
|
Diabetic Retinopathy | 1 | 2021 | 1210 | 0.110 |
Why?
|
Psychometrics | 1 | 2021 | 3002 | 0.100 |
Why?
|
Chi-Square Distribution | 3 | 2015 | 3509 | 0.100 |
Why?
|
Validation Studies as Topic | 1 | 2012 | 159 | 0.100 |
Why?
|
Program Evaluation | 1 | 2020 | 2486 | 0.100 |
Why?
|
Premature Birth | 1 | 2023 | 1721 | 0.100 |
Why?
|
Sex Distribution | 4 | 2020 | 2297 | 0.100 |
Why?
|
Autoantibodies | 1 | 2019 | 2038 | 0.090 |
Why?
|
Adenoma | 1 | 2021 | 2174 | 0.090 |
Why?
|
Age Factors | 5 | 2019 | 18367 | 0.090 |
Why?
|
Residence Characteristics | 1 | 2020 | 2050 | 0.090 |
Why?
|
Calcium | 1 | 2023 | 5757 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19907 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1888 | 0.090 |
Why?
|
Retrospective Studies | 8 | 2022 | 77426 | 0.090 |
Why?
|
Time Factors | 11 | 2021 | 40063 | 0.090 |
Why?
|
Predictive Value of Tests | 6 | 2019 | 15070 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6535 | 0.090 |
Why?
|
Cost-Benefit Analysis | 1 | 2023 | 5396 | 0.090 |
Why?
|
Adolescent | 12 | 2021 | 85759 | 0.090 |
Why?
|
Lipoproteins | 1 | 2014 | 878 | 0.090 |
Why?
|
Quality Control | 1 | 2012 | 843 | 0.080 |
Why?
|
Neoplasms | 2 | 2022 | 21672 | 0.080 |
Why?
|
National Health Programs | 1 | 2012 | 445 | 0.080 |
Why?
|
Infertility, Female | 1 | 2015 | 787 | 0.080 |
Why?
|
Aged, 80 and over | 7 | 2022 | 57768 | 0.080 |
Why?
|
Pregnancy Outcome | 3 | 2023 | 2796 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2021 | 2987 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2021 | 21752 | 0.080 |
Why?
|
Propensity Score | 3 | 2023 | 1781 | 0.080 |
Why?
|
Feeding Behavior | 1 | 2020 | 3188 | 0.080 |
Why?
|
Hospital Mortality | 1 | 2021 | 5316 | 0.080 |
Why?
|
Public Health | 1 | 2020 | 2603 | 0.080 |
Why?
|
Students | 1 | 2017 | 1654 | 0.080 |
Why?
|
Research Design | 1 | 2023 | 5987 | 0.070 |
Why?
|
United States | 4 | 2021 | 69867 | 0.070 |
Why?
|
Hyperglycemia | 1 | 2016 | 1372 | 0.070 |
Why?
|
Survival Rate | 4 | 2016 | 12781 | 0.070 |
Why?
|
Fasting | 2 | 2023 | 1591 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1797 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2022 | 3444 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2019 | 3297 | 0.070 |
Why?
|
Medical Records | 1 | 2012 | 1413 | 0.070 |
Why?
|
False Positive Reactions | 2 | 2019 | 981 | 0.070 |
Why?
|
Regression Analysis | 2 | 2015 | 6461 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2015 | 1333 | 0.070 |
Why?
|
Pregnancy | 6 | 2023 | 29142 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2018 | 14726 | 0.070 |
Why?
|
Vitamin D | 1 | 2019 | 3222 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2015 | 2942 | 0.060 |
Why?
|
Air Pollution | 1 | 2019 | 2286 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2019 | 3336 | 0.060 |
Why?
|
Glomerular Filtration Rate | 3 | 2021 | 2170 | 0.060 |
Why?
|
Weight Loss | 3 | 2022 | 2622 | 0.060 |
Why?
|
Patient Compliance | 3 | 2020 | 2684 | 0.060 |
Why?
|
Age Distribution | 3 | 2018 | 2903 | 0.060 |
Why?
|
Stroke | 3 | 2018 | 9981 | 0.060 |
Why?
|
Cesarean Section | 2 | 2023 | 1365 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10250 | 0.060 |
Why?
|
Registries | 2 | 2011 | 8090 | 0.060 |
Why?
|
Infant | 2 | 2023 | 35129 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2011 | 7908 | 0.060 |
Why?
|
Medical Assistance | 1 | 2024 | 104 | 0.060 |
Why?
|
Universities | 2 | 2020 | 956 | 0.060 |
Why?
|
World Health Organization | 1 | 2009 | 1318 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2023 | 130 | 0.050 |
Why?
|
Artificial Intelligence | 1 | 2015 | 2213 | 0.050 |
Why?
|
Asia | 1 | 2023 | 610 | 0.050 |
Why?
|
Intubation | 1 | 2021 | 141 | 0.050 |
Why?
|
Likelihood Functions | 1 | 2024 | 1005 | 0.050 |
Why?
|
Capsules | 1 | 2020 | 197 | 0.050 |
Why?
|
Subcutaneous Fat | 1 | 2023 | 391 | 0.040 |
Why?
|
Persia | 1 | 2019 | 6 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2021 | 402 | 0.040 |
Why?
|
Epidemiologic Methods | 2 | 2015 | 1365 | 0.040 |
Why?
|
Referral and Consultation | 2 | 2023 | 3528 | 0.040 |
Why?
|
Glycemic Index | 1 | 2022 | 395 | 0.040 |
Why?
|
Health Transition | 1 | 2019 | 34 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8426 | 0.040 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2020 | 194 | 0.040 |
Why?
|
Ritonavir | 1 | 2021 | 322 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2023 | 853 | 0.040 |
Why?
|
Algorithms | 2 | 2022 | 13885 | 0.040 |
Why?
|
Research Personnel | 1 | 2024 | 573 | 0.040 |
Why?
|
Antihypertensive Agents | 2 | 2019 | 2047 | 0.040 |
Why?
|
History, Ancient | 1 | 2019 | 212 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2012 | 3265 | 0.040 |
Why?
|
Child, Preschool | 1 | 2021 | 40992 | 0.040 |
Why?
|
Reference Values | 2 | 2018 | 4982 | 0.040 |
Why?
|
Intra-Abdominal Fat | 1 | 2023 | 591 | 0.040 |
Why?
|
Focus Groups | 1 | 2022 | 1321 | 0.040 |
Why?
|
Medical Audit | 1 | 2019 | 467 | 0.040 |
Why?
|
Internationality | 1 | 2023 | 1003 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2015 | 6352 | 0.040 |
Why?
|
Heart Failure | 1 | 2021 | 10905 | 0.040 |
Why?
|
Systole | 1 | 2019 | 957 | 0.040 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2020 | 548 | 0.040 |
Why?
|
Hydroxychloroquine | 1 | 2021 | 412 | 0.040 |
Why?
|
Diastole | 1 | 2019 | 791 | 0.040 |
Why?
|
Hip | 1 | 2018 | 257 | 0.040 |
Why?
|
Behavior | 1 | 2019 | 560 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6489 | 0.030 |
Why?
|
Remission Induction | 1 | 2021 | 2389 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2020 | 2032 | 0.030 |
Why?
|
Causality | 1 | 2021 | 1275 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2022 | 63119 | 0.030 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2015 | 153 | 0.030 |
Why?
|
Qualitative Research | 1 | 2022 | 2682 | 0.030 |
Why?
|
Awareness | 1 | 2018 | 640 | 0.030 |
Why?
|
Medical History Taking | 1 | 2017 | 783 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2023 | 2715 | 0.030 |
Why?
|
Linear Models | 1 | 2023 | 5953 | 0.030 |
Why?
|
Marital Status | 1 | 2014 | 437 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 1683 | 0.030 |
Why?
|
Hospitalization | 2 | 2022 | 10262 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2355 | 0.030 |
Why?
|
Calibration | 1 | 2015 | 816 | 0.030 |
Why?
|
Fatty Acids | 1 | 2020 | 1808 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2015 | 977 | 0.030 |
Why?
|
Diet Surveys | 1 | 2016 | 1173 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2023 | 3107 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2015 | 940 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15538 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2023 | 3278 | 0.020 |
Why?
|
Premenopause | 1 | 2015 | 1033 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6485 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3176 | 0.020 |
Why?
|
Comorbidity | 2 | 2016 | 10387 | 0.020 |
Why?
|
Computer Simulation | 1 | 2023 | 6196 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2015 | 969 | 0.020 |
Why?
|
Oxygen | 1 | 2021 | 4187 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2021 | 4559 | 0.020 |
Why?
|
Social Class | 1 | 2018 | 1999 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 13036 | 0.020 |
Why?
|
Down-Regulation | 1 | 2015 | 3001 | 0.020 |
Why?
|
Employment | 1 | 2014 | 1129 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6308 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8343 | 0.020 |
Why?
|
Parents | 1 | 2021 | 3407 | 0.020 |
Why?
|
Research Report | 1 | 2010 | 355 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12035 | 0.020 |
Why?
|
Reference Standards | 1 | 2010 | 1025 | 0.020 |
Why?
|
Postmenopause | 1 | 2015 | 2461 | 0.020 |
Why?
|
Child | 3 | 2018 | 77679 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2017 | 2408 | 0.020 |
Why?
|
Phenotype | 1 | 2022 | 16365 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2014 | 1955 | 0.010 |
Why?
|
Computational Biology | 1 | 2014 | 3523 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8387 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10480 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16687 | 0.010 |
Why?
|
Societies, Medical | 1 | 2010 | 3741 | 0.010 |
Why?
|
Concepts
(322)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_